Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Citi
Moodys
US Army
Cipla
Daiichi Sankyo
Accenture
Fuji
Deloitte

Generated: August 19, 2017

DrugPatentWatch Database Preview

Almotriptan malate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for almotriptan malate and what is the scope of almotriptan malate patent protection?

Almotriptan malate
is the generic ingredient in two branded drugs marketed by Janssen Pharms, Ajanta Pharma Ltd, Teva Pharms Usa, and Mylan Pharms Inc, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for almotriptan malate. Six suppliers are listed for this compound.

Summary for Generic Name: almotriptan malate

Tradenames:2
Patents:0
Applicants:4
NDAs:4
Drug Master File Entries: see list6
Suppliers / Packagers: see list6
Bulk Api Vendors: see list39
Clinical Trials: see list191
Patent Applications: see list329
Therapeutic Class:Antimigraine Agents
Drug Prices:see low prices
DailyMed Link:almotriptan malate at DailyMed

Pharmacology for Ingredient: almotriptan malate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL205171-002Nov 9, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Janssen Pharms
AXERT
almotriptan malate
TABLET;ORAL021001-002May 7, 2001ABRXYesYes► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL205523-001Mar 3, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL078027-001Jul 7, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL078027-002Jul 7, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: almotriptan malate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
AXERT
almotriptan malate
TABLET;ORAL021001-001May 7, 2001► Subscribe► Subscribe
Janssen Pharms
AXERT
almotriptan malate
TABLET;ORAL021001-002May 7, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Medtronic
Accenture
Johnson and Johnson
UBS
Julphar
Farmers Insurance
Baxter
Cantor Fitzgerald
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot